a
Here are 10 key notes on orthopedic and spine device companies over the past week.
The North American joint reconstruction market has four companies dominating the space, which continues to grow.

3. Orchid opens new India plant — 5 things to know

Written by Laura Dyrda | Friday, 22 May 2015 00:00
Orchid opened a new facility in India earlier this year.

4. 8 trends in the China orthopedic instrument market

Written by Laura Dyrda | Friday, 22 May 2015 00:00
The China orthopedic instrument market is expected to grow significantly over the next few years, according to a new report from ReportBuyer report.
TheraCell's board of directors appointed Gunnar B.J. Andersson, MD, PhD, as director of the company and member of the surgeon advisory board.
China-based Weigao Orthopaedic Device is now offering a spinal stabilization system called "Tulip" for semi-rigid rods made from PEEK-OPTIMA to bridge the gap between rigid and dynamic systems.
Here are the stock reports from five spine device companies for May 21, 2015 and how they compare to their numbers two weeks ago on May 14.
The United States spine navigation system market is poised for growth, according to a new iData Research report.

9. OrthoSpace completes financing — 5 key notes

Written by Laura Dyrda | Wednesday, 20 May 2015 00:00
OrthoSpace completed financing which will facilitate growth in the future.
Medtronic's fourth quarter preliminary report is outpacing estimates.
The Food and Drug Administration granted 47 orthopedic- and spine-related devices in April.
InVivo Therapeutics named a new site for the ongoing Neuro-Spinal Scaffold for patients with acute spinal cord injury.
Implanet received FDA clearance to market its 3.5 mm, 4 mm, 4.5 mm and 6 mm JAZZ rods in the United States.
LDR COO James Burrows sold several shares of the company last Friday, according to a Mideast Times report.
The Utah Innovation Award in Life Sciences—Medical Device category went to CoNextions Medical at their annual meeting in April.
Medtronic is pledging several thousand dollars to support earthquake relief efforts in Nepal.
Biologic Therapies received U.S. Food and Drug Administration clearance for the Bio-MAC and Bio-CORE Bone Marrow Cannulas.

18. LDR, MEDTECH, Paradigm Spine & more — 14 key notes

Written by Anuja Vaidya | Friday, 15 May 2015 00:00
Here are 14 key notes on spine and orthopedic device companies this week.
Smith & Nephew has acquired two software assets from S2 Interactive.
Brussels-based Bone Therapeutics reported first quarter results.
  • «
  •  Prev 
  •  1 
  •  2 
  •  3 
  •  4 
  •  5 
  •  6 
  •  7 
  •  8 
  •  9 
  •  10 
  •  Next 
  • »
Page 1 of 213